Agra Ventures Ltd.
Agra Ventures Ltd. AGFAF Peers
See (AGFAF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AGFAF | $0.02 | N/A | 341.9K | 0.03 | $0.61 | N/A |
| MKGAF | $135.44 | -0.60% | 58.9B | 18.28 | $7.41 | +1.60% |
| MKKGY | $26.39 | -1.68% | 56.7B | 17.71 | $1.49 | +2.19% |
| HLNCF | $5.27 | -2.30% | 47.4B | 25.08 | $0.21 | +2.07% |
| TKPHF | $28.27 | +1.29% | 44.5B | 60.15 | $0.47 | +4.71% |
| IPSEY | $29.84 | +0.64% | 39.5B | 24.46 | $1.22 | +0.75% |
| SDZNY | $52.43 | -1.75% | 22.6B | -2621.25 | -$0.02 | +1.29% |
| TEVJF | $17.80 | N/A | 20.4B | -15.48 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| SGIOY | $8.58 | +0.59% | 14.6B | 12.43 | $0.69 | +0.82% |
Stock Comparison
AGFAF vs MKGAF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, MKGAF has a market cap of 58.9B. Regarding current trading prices, AGFAF is priced at $0.02, while MKGAF trades at $135.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas MKGAF's P/E ratio is 18.28. In terms of profitability, AGFAF's ROE is +0.84%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, AGFAF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs MKKGY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, MKKGY has a market cap of 56.7B. Regarding current trading prices, AGFAF is priced at $0.02, while MKKGY trades at $26.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas MKKGY's P/E ratio is 17.71. In terms of profitability, AGFAF's ROE is +0.84%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, AGFAF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HLNCF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HLNCF has a market cap of 47.4B. Regarding current trading prices, AGFAF is priced at $0.02, while HLNCF trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HLNCF's P/E ratio is 25.08. In terms of profitability, AGFAF's ROE is +0.84%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, AGFAF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs TKPHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, TKPHF has a market cap of 44.5B. Regarding current trading prices, AGFAF is priced at $0.02, while TKPHF trades at $28.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas TKPHF's P/E ratio is 60.15. In terms of profitability, AGFAF's ROE is +0.84%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, AGFAF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs IPSEY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, IPSEY has a market cap of 39.5B. Regarding current trading prices, AGFAF is priced at $0.02, while IPSEY trades at $29.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas IPSEY's P/E ratio is 24.46. In terms of profitability, AGFAF's ROE is +0.84%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, AGFAF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SDZNY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SDZNY has a market cap of 22.6B. Regarding current trading prices, AGFAF is priced at $0.02, while SDZNY trades at $52.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SDZNY's P/E ratio is -2621.25. In terms of profitability, AGFAF's ROE is +0.84%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, AGFAF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs TEVJF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, TEVJF has a market cap of 20.4B. Regarding current trading prices, AGFAF is priced at $0.02, while TEVJF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas TEVJF's P/E ratio is -15.48. In terms of profitability, AGFAF's ROE is +0.84%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, AGFAF is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs ESALY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, AGFAF is priced at $0.02, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas ESALY's P/E ratio is 20.54. In terms of profitability, AGFAF's ROE is +0.84%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, AGFAF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SGIOY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SGIOY has a market cap of 14.6B. Regarding current trading prices, AGFAF is priced at $0.02, while SGIOY trades at $8.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SGIOY's P/E ratio is 12.43. In terms of profitability, AGFAF's ROE is +0.84%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, AGFAF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SGIOF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SGIOF has a market cap of 12.9B. Regarding current trading prices, AGFAF is priced at $0.02, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SGIOF's P/E ratio is 11.01. In terms of profitability, AGFAF's ROE is +0.84%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, AGFAF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs BIOVF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, BIOVF has a market cap of 11B. Regarding current trading prices, AGFAF is priced at $0.02, while BIOVF trades at $31.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas BIOVF's P/E ratio is 26.88. In terms of profitability, AGFAF's ROE is +0.84%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, AGFAF is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs IPSEF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, IPSEF has a market cap of 10.4B. Regarding current trading prices, AGFAF is priced at $0.02, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas IPSEF's P/E ratio is 25.74. In terms of profitability, AGFAF's ROE is +0.84%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, AGFAF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs ESALF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, ESALF has a market cap of 8.3B. Regarding current trading prices, AGFAF is priced at $0.02, while ESALF trades at $29.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas ESALF's P/E ratio is 25.94. In terms of profitability, AGFAF's ROE is +0.84%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, AGFAF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs ESAIY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, ESAIY has a market cap of 7.9B. Regarding current trading prices, AGFAF is priced at $0.02, while ESAIY trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas ESAIY's P/E ratio is 25.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, AGFAF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SFOSF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SFOSF has a market cap of 7.8B. Regarding current trading prices, AGFAF is priced at $0.02, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, AGFAF's ROE is +0.84%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, AGFAF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HKMPY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HKMPY has a market cap of 6.3B. Regarding current trading prices, AGFAF is priced at $0.02, while HKMPY trades at $56.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HKMPY's P/E ratio is 17.67. In terms of profitability, AGFAF's ROE is +0.84%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, AGFAF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HKMPF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HKMPF has a market cap of 6.1B. Regarding current trading prices, AGFAF is priced at $0.02, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, AGFAF's ROE is +0.84%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, AGFAF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs GZPHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, GZPHF has a market cap of 5.6B. Regarding current trading prices, AGFAF is priced at $0.02, while GZPHF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas GZPHF's P/E ratio is 9.57. In terms of profitability, AGFAF's ROE is +0.84%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, AGFAF is less volatile compared to GZPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs WIBFF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, AGFAF is priced at $0.02, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, AGFAF's ROE is +0.84%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, AGFAF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HLBBF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HLBBF has a market cap of 4.5B. Regarding current trading prices, AGFAF is priced at $0.02, while HLBBF trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HLBBF's P/E ratio is 11.71. In terms of profitability, AGFAF's ROE is +0.84%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, AGFAF is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs LVZPF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, LVZPF has a market cap of 3.8B. Regarding current trading prices, AGFAF is priced at $0.02, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, AGFAF's ROE is +0.84%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, AGFAF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HLUBF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HLUBF has a market cap of 3.6B. Regarding current trading prices, AGFAF is priced at $0.02, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HLUBF's P/E ratio is 7.25. In terms of profitability, AGFAF's ROE is +0.84%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, AGFAF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs APNHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, AGFAF is priced at $0.02, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas APNHF's P/E ratio is 12.72. In terms of profitability, AGFAF's ROE is +0.84%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, AGFAF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs INVVY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, AGFAF is priced at $0.02, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas INVVY's P/E ratio is -62.42. In terms of profitability, AGFAF's ROE is +0.84%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, AGFAF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs APNHY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, AGFAF is priced at $0.02, while APNHY trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas APNHY's P/E ratio is 11.68. In terms of profitability, AGFAF's ROE is +0.84%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, AGFAF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HYPMY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, AGFAF is priced at $0.02, while HYPMY trades at $4.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HYPMY's P/E ratio is 20.17. In terms of profitability, AGFAF's ROE is +0.84%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, AGFAF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs IZQVF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, AGFAF is priced at $0.02, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, AGFAF's ROE is +0.84%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, AGFAF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HMDCF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, AGFAF is priced at $0.02, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, AGFAF's ROE is +0.84%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, AGFAF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs DNPUF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, DNPUF has a market cap of 2.6B. Regarding current trading prices, AGFAF is priced at $0.02, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas DNPUF's P/E ratio is 15.93. In terms of profitability, AGFAF's ROE is +0.84%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, AGFAF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs ULIHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, ULIHF has a market cap of 2.5B. Regarding current trading prices, AGFAF is priced at $0.02, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, AGFAF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs THCBF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, AGFAF is priced at $0.02, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas THCBF's P/E ratio is -0.10. In terms of profitability, AGFAF's ROE is +0.84%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, AGFAF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CHSYF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, AGFAF is priced at $0.02, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, AGFAF's ROE is +0.84%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, AGFAF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs TSMRF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, AGFAF is priced at $0.02, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, AGFAF's ROE is +0.84%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, AGFAF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs DMPHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, AGFAF is priced at $0.02, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas DMPHF's P/E ratio is 18.06. In terms of profitability, AGFAF's ROE is +0.84%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, AGFAF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HTSUF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, AGFAF is priced at $0.02, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HTSUF's P/E ratio is 14.19. In terms of profitability, AGFAF's ROE is +0.84%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, AGFAF is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs LJUIF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, AGFAF is priced at $0.02, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, AGFAF's ROE is +0.84%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, AGFAF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs LBTSF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, LBTSF has a market cap of 1.9B. Regarding current trading prices, AGFAF is priced at $0.02, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, AGFAF's ROE is +0.84%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, AGFAF is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs ARSUF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, AGFAF is priced at $0.02, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, AGFAF's ROE is +0.84%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, AGFAF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs NPNKF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, AGFAF is priced at $0.02, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas NPNKF's P/E ratio is 7.66. In terms of profitability, AGFAF's ROE is +0.84%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, AGFAF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs NPPNY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, NPPNY has a market cap of 1.7B. Regarding current trading prices, AGFAF is priced at $0.02, while NPPNY trades at $6.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas NPPNY's P/E ratio is 7.45. In terms of profitability, AGFAF's ROE is +0.84%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, AGFAF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SMDPY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SMDPY has a market cap of 1.6B. Regarding current trading prices, AGFAF is priced at $0.02, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SMDPY's P/E ratio is 9.76. In terms of profitability, AGFAF's ROE is +0.84%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, AGFAF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs MITPF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, AGFAF is priced at $0.02, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas MITPF's P/E ratio is -10.81. In terms of profitability, AGFAF's ROE is +0.84%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, AGFAF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SHEZF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SHEZF has a market cap of 1.6B. Regarding current trading prices, AGFAF is priced at $0.02, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, AGFAF's ROE is +0.84%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, AGFAF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs YIHCF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, AGFAF is priced at $0.02, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, AGFAF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs KARBF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, AGFAF is priced at $0.02, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas KARBF's P/E ratio is 262.50. In terms of profitability, AGFAF's ROE is +0.84%, compared to KARBF's ROE of N/A. Regarding short-term risk, AGFAF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs EVOTF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, AGFAF is priced at $0.02, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, AGFAF's ROE is +0.84%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, AGFAF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CHIZF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CHIZF has a market cap of 1.2B. Regarding current trading prices, AGFAF is priced at $0.02, while CHIZF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CHIZF's P/E ratio is 12.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, AGFAF is less volatile compared to CHIZF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs GTBIF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, AGFAF is priced at $0.02, while GTBIF trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas GTBIF's P/E ratio is 23.57. In terms of profitability, AGFAF's ROE is +0.84%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, AGFAF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs KSPHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, AGFAF is priced at $0.02, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas KSPHF's P/E ratio is 14.35. In terms of profitability, AGFAF's ROE is +0.84%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, AGFAF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SWGHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, AGFAF is priced at $0.02, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, AGFAF's ROE is +0.84%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, AGFAF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs GNMLF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, AGFAF is priced at $0.02, while GNMLF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas GNMLF's P/E ratio is 10.36. In terms of profitability, AGFAF's ROE is +0.84%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, AGFAF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CASBF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CASBF has a market cap of 985.6M. Regarding current trading prices, AGFAF is priced at $0.02, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CASBF's P/E ratio is -15.24. In terms of profitability, AGFAF's ROE is +0.84%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, AGFAF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs KKPCF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, KKPCF has a market cap of 980.3M. Regarding current trading prices, AGFAF is priced at $0.02, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas KKPCF's P/E ratio is 10.54. In terms of profitability, AGFAF's ROE is +0.84%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, AGFAF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SHPHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, AGFAF is priced at $0.02, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, AGFAF's ROE is +0.84%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, AGFAF is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs LVTTF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, LVTTF has a market cap of 897.2M. Regarding current trading prices, AGFAF is priced at $0.02, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, AGFAF's ROE is +0.84%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, AGFAF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs EVRRF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, EVRRF has a market cap of 893.5M. Regarding current trading prices, AGFAF is priced at $0.02, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, AGFAF's ROE is +0.84%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, AGFAF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs BIOGY Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, AGFAF is priced at $0.02, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, AGFAF's ROE is +0.84%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, AGFAF is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs NRXCF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, NRXCF has a market cap of 846.2M. Regarding current trading prices, AGFAF is priced at $0.02, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, AGFAF's ROE is +0.84%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, AGFAF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs TWAPF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, AGFAF is priced at $0.02, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas TWAPF's P/E ratio is 6.33. In terms of profitability, AGFAF's ROE is +0.84%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, AGFAF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CSWYF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, AGFAF is priced at $0.02, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, AGFAF's ROE is +0.84%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, AGFAF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs ELTP Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, ELTP has a market cap of 721.1M. Regarding current trading prices, AGFAF is priced at $0.02, while ELTP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas ELTP's P/E ratio is -33.75. In terms of profitability, AGFAF's ROE is +0.84%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, AGFAF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs NIKA Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, AGFAF is priced at $0.02, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas NIKA's P/E ratio is N/A. In terms of profitability, AGFAF's ROE is +0.84%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, AGFAF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs TCNNF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, TCNNF has a market cap of 703.3M. Regarding current trading prices, AGFAF is priced at $0.02, while TCNNF trades at $3.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas TCNNF's P/E ratio is -4.66. In terms of profitability, AGFAF's ROE is +0.84%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, AGFAF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs TRXPF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, AGFAF is priced at $0.02, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, AGFAF's ROE is +0.84%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, AGFAF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SWDCF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SWDCF has a market cap of 679.3M. Regarding current trading prices, AGFAF is priced at $0.02, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, AGFAF's ROE is +0.84%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, AGFAF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CURLF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CURLF has a market cap of 602M. Regarding current trading prices, AGFAF is priced at $0.02, while CURLF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CURLF's P/E ratio is -2.41. In terms of profitability, AGFAF's ROE is +0.84%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, AGFAF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs TRSSF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, AGFAF is priced at $0.02, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, AGFAF's ROE is +0.84%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, AGFAF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs SGFEF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, SGFEF has a market cap of 536.8M. Regarding current trading prices, AGFAF is priced at $0.02, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas SGFEF's P/E ratio is 22.83. In terms of profitability, AGFAF's ROE is +0.84%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, AGFAF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CCHWF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, AGFAF is priced at $0.02, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, AGFAF's ROE is +0.84%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, AGFAF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs AIHLF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, AIHLF has a market cap of 507.8M. Regarding current trading prices, AGFAF is priced at $0.02, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, AGFAF's ROE is +0.84%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, AGFAF is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs BOIRF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, AGFAF is priced at $0.02, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, AGFAF's ROE is +0.84%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, AGFAF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs PEXXF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, AGFAF is priced at $0.02, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to PEXXF's ROE of N/A. Regarding short-term risk, AGFAF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs KHTRF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, KHTRF has a market cap of 443.1M. Regarding current trading prices, AGFAF is priced at $0.02, while KHTRF trades at $4.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas KHTRF's P/E ratio is 63.54. In terms of profitability, AGFAF's ROE is +0.84%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, AGFAF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs AGYTF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, AGFAF is priced at $0.02, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, AGFAF's ROE is +0.84%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, AGFAF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs PKBFF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, PKBFF has a market cap of 292.3M. Regarding current trading prices, AGFAF is priced at $0.02, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, AGFAF is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs ABTI Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, ABTI has a market cap of 291.9M. Regarding current trading prices, AGFAF is priced at $0.02, while ABTI trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas ABTI's P/E ratio is -20.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to ABTI's ROE of -0.15%. Regarding short-term risk, AGFAF is more volatile compared to ABTI. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs GLASF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, GLASF has a market cap of 271.3M. Regarding current trading prices, AGFAF is priced at $0.02, while GLASF trades at $4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas GLASF's P/E ratio is -55.44. In terms of profitability, AGFAF's ROE is +0.84%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, AGFAF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs BHCCF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, BHCCF has a market cap of 271.2M. Regarding current trading prices, AGFAF is priced at $0.02, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, AGFAF's ROE is +0.84%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, AGFAF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CPHRF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CPHRF has a market cap of 245.2M. Regarding current trading prices, AGFAF is priced at $0.02, while CPHRF trades at $9.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CPHRF's P/E ratio is 26.58. In terms of profitability, AGFAF's ROE is +0.84%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, AGFAF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs PLNHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, AGFAF is priced at $0.02, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, AGFAF's ROE is +0.84%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, AGFAF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs VRNOF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, VRNOF has a market cap of 178.2M. Regarding current trading prices, AGFAF is priced at $0.02, while VRNOF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas VRNOF's P/E ratio is -0.50. In terms of profitability, AGFAF's ROE is +0.84%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, AGFAF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CBSTF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CBSTF has a market cap of 174M. Regarding current trading prices, AGFAF is priced at $0.02, while CBSTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CBSTF's P/E ratio is -0.24. In terms of profitability, AGFAF's ROE is +0.84%, compared to CBSTF's ROE of +10.11%. Regarding short-term risk, AGFAF is less volatile compared to CBSTF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CRLBF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CRLBF has a market cap of 169.2M. Regarding current trading prices, AGFAF is priced at $0.02, while CRLBF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CRLBF's P/E ratio is -2.09. In terms of profitability, AGFAF's ROE is +0.84%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, AGFAF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HUMDF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HUMDF has a market cap of 147.5M. Regarding current trading prices, AGFAF is priced at $0.02, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, AGFAF's ROE is +0.84%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, AGFAF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs PHCUF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, PHCUF has a market cap of 139.6M. Regarding current trading prices, AGFAF is priced at $0.02, while PHCUF trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas PHCUF's P/E ratio is 524.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, AGFAF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs COPHF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, AGFAF is priced at $0.02, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas COPHF's P/E ratio is -0.02. In terms of profitability, AGFAF's ROE is +0.84%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, AGFAF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HLTRF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HLTRF has a market cap of 115.8M. Regarding current trading prices, AGFAF is priced at $0.02, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HLTRF's P/E ratio is -6.42. In terms of profitability, AGFAF's ROE is +0.84%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, AGFAF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs LPCUF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, AGFAF is priced at $0.02, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, AGFAF's ROE is +0.84%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, AGFAF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CNVCF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, AGFAF is priced at $0.02, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, AGFAF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs BIOYF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, BIOYF has a market cap of 101.2M. Regarding current trading prices, AGFAF is priced at $0.02, while BIOYF trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas BIOYF's P/E ratio is 18.00. In terms of profitability, AGFAF's ROE is +0.84%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, AGFAF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs NWPN Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, NWPN has a market cap of 100.8M. Regarding current trading prices, AGFAF is priced at $0.02, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas NWPN's P/E ratio is -0.03. In terms of profitability, AGFAF's ROE is +0.84%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, AGFAF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs HBRM Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, HBRM has a market cap of 96.3M. Regarding current trading prices, AGFAF is priced at $0.02, while HBRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas HBRM's P/E ratio is N/A. In terms of profitability, AGFAF's ROE is +0.84%, compared to HBRM's ROE of +0.08%. Regarding short-term risk, AGFAF is less volatile compared to HBRM. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs DUTV Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, DUTV has a market cap of 93.2M. Regarding current trading prices, AGFAF is priced at $0.02, while DUTV trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas DUTV's P/E ratio is N/A. In terms of profitability, AGFAF's ROE is +0.84%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, AGFAF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs LRDSF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, LRDSF has a market cap of 84.3M. Regarding current trading prices, AGFAF is priced at $0.02, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, AGFAF's ROE is +0.84%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, AGFAF is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs GRUSF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, GRUSF has a market cap of 84M. Regarding current trading prices, AGFAF is priced at $0.02, while GRUSF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas GRUSF's P/E ratio is -6.78. In terms of profitability, AGFAF's ROE is +0.84%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, AGFAF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs GBLP Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, GBLP has a market cap of 83M. Regarding current trading prices, AGFAF is priced at $0.02, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas GBLP's P/E ratio is -0.67. In terms of profitability, AGFAF's ROE is +0.84%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, AGFAF is more volatile compared to GBLP. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs LOVFF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, LOVFF has a market cap of 82.5M. Regarding current trading prices, AGFAF is priced at $0.02, while LOVFF trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas LOVFF's P/E ratio is 9.02. In terms of profitability, AGFAF's ROE is +0.84%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, AGFAF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs CBWTF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, CBWTF has a market cap of 80M. Regarding current trading prices, AGFAF is priced at $0.02, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas CBWTF's P/E ratio is 3.04. In terms of profitability, AGFAF's ROE is +0.84%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, AGFAF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.
AGFAF vs ABSCF Comparison
AGFAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGFAF stands at 341.9K. In comparison, ABSCF has a market cap of 74.8M. Regarding current trading prices, AGFAF is priced at $0.02, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGFAF currently has a P/E ratio of 0.03, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, AGFAF's ROE is +0.84%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, AGFAF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for AGFAF.